PMC:7441788 / 1073-1418
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T13 | 207-215 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T14 | 302-310 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T6 | 143-144 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T13 | 106-108 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T14 | 145-154 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
T15 | 279-281 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T10 | 106-108 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T11 | 145-154 | Chemical | denotes | macrolide | http://purl.obolibrary.org/obo/CHEBI_25106 |
T12 | 279-281 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T11 | 207-215 | Species | denotes | COVID-19 | NCBItxid:2697049 |
T12 | 302-310 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 56-216 | Sentence | denotes | However, recent studies indicated that the use of CQ/HCQ, alone or in combination with a macrolide, did not show any favorable effect on patients with COVID-19. |
T15 | 217-320 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
46 | 193-201 | Species | denotes | patients | Tax:9606 |
47 | 311-319 | Species | denotes | patients | Tax:9606 |
55 | 106-112 | Chemical | denotes | CQ/HCQ | |
56 | 145-154 | Chemical | denotes | macrolide | MESH:D018942 |
57 | 279-281 | Chemical | denotes | CQ | MESH:D002738 |
58 | 282-285 | Chemical | denotes | HCQ | MESH:D006886 |
70 | 207-215 | Disease | denotes | COVID-19 | MESH:C000657245 |
71 | 302-310 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-IDO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T4 | 0-7 | http://purl.obolibrary.org/obo/OGMS_0000031 | denotes | disease |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T11 | 207-215 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
T12 | 302-310 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-sample-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 244-265 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
46 | 193-201 | Species | denotes | patients | Tax:9606 |
47 | 311-319 | Species | denotes | patients | Tax:9606 |
55 | 106-112 | Chemical | denotes | CQ/HCQ | |
56 | 145-154 | Chemical | denotes | macrolide | MESH:D018942 |
57 | 279-281 | Chemical | denotes | CQ | MESH:D002738 |
58 | 282-285 | Chemical | denotes | HCQ | MESH:D006886 |
70 | 207-215 | Disease | denotes | COVID-19 | MESH:C000657245 |
71 | 302-310 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T14 | 56-216 | Sentence | denotes | However, recent studies indicated that the use of CQ/HCQ, alone or in combination with a macrolide, did not show any favorable effect on patients with COVID-19. |
T15 | 217-320 | Sentence | denotes | Adverse effects, including prolonged QT interval after taking CQ/HCQ, may develop in COVID-19 patients. |
LitCovid-PD-HP
Id | Subject | Object | Predicate | Lexical cue | hp_id |
---|---|---|---|---|---|
T1 | 244-265 | Phenotype | denotes | prolonged QT interval | http://purl.obolibrary.org/obo/HP_0001657 |